Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
129,668,560
-
Number of holders
-
278
-
Total 13F shares, excl. options
-
120,319,823
-
Shares change
-
+2,956,254
-
Total reported value, excl. options
-
$1,480,068,392
-
Value change
-
+$31,109,122
-
Put/Call ratio
-
32%
-
Number of buys
-
105
-
Number of sells
-
-124
-
Price
-
$12.30
Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q3 2023
307 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q3 2023.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 278 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 120,319,823 shares
of 129,668,560 outstanding shares and own 93% of the company stock.
Largest 10 shareholders include BlackRock Inc. (20,102,908 shares), VANGUARD GROUP INC (14,316,201 shares), BROWN ADVISORY INC (8,246,202 shares), JANUS HENDERSON GROUP PLC (7,174,427 shares), T. Rowe Price Investment Management, Inc. (5,526,219 shares), STATE STREET CORP (4,924,489 shares), Greenhouse Funds LLLP (3,981,003 shares), First Light Asset Management, LLC (3,028,913 shares), MACQUARIE GROUP LTD (3,018,953 shares), and DIMENSIONAL FUND ADVISORS LP (2,987,920 shares).
This table shows the top 278 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.